Literature DB >> 32662552

Binding affinities of oxytocin, vasopressin and Manning compound at oxytocin and V1a receptors in male Syrian hamster brains.

Jack H Taylor1,2, Katharine E McCann1,2, Amy P Ross1,2, H Elliott Albers1,2.   

Abstract

Oxytocin (OT) and arginine vasopressin (AVP), as well as synthetic ligands targeting their receptors (OTR, V1aR), are used in a wide variety of research contexts, although their pharmacological properties are determined in only a few species. Syrian hamsters (Mesocricetus auratus) have a long history of use as a behavioural and biomedical model for the study of OT and AVP and, more recently, hamsters have been used to investigate behavioural consequences of OT-mediated activation of V1aR. We aimed to determine the binding affinities of OT, AVP and the selective V1aR antagonist, Manning compound, for OTR and V1aR in hamster brains. We performed saturation binding assays to determine the Kd values for the selective OTR and V1aR radioligands, [125 I]ornithine vasotocin analogue and [125 I]linear vasopressin antagonist. We then performed competition binding assays to determine Ki values for OT, AVP and Manning compound at both the OTR and V1aR. We found that OT and AVP each had the highest affinity for their canonical receptors (OT-OTR Ki = 4.28 [95% confidence interval (CI) = 2.9-6.3] nmol L-1 ; AVP-V1ar Ki = 4.70 [95% CI = 1.5-14.1] nmol L-1 ) and had the lowest affinity for their non-canonical ligands (OT-V1aR = 495.2 [95% CI = 198.5-1276] nmol L-1 ; AVP-OTR Ki = 36.1 [95% CI = 12.4-97.0] nmol L-1 ). Manning compound had the highest affinity for the V1aR (MC-V1aR Ki = 6.87 [95% CI = 4.0-11.9] nmol L-1 ; MC-OTR Ki = 213.8 [95% CI = 117.3-392.7] nmol L-1 ), although Manning compound was not as selective for the V1aR in hamsters as has been reported for the receptor in rats. When comparing these data with previously published work, we found that the promiscuity of the V1aR in hamsters with respect to OT and AVP binding is more similar to the promiscuity of the human V1aR than to the rat V1aR receptor. Moreover, the selectivity of OT at hamster receptors is more similar to the selectivity of OT at human receptors than the selectivity of OT at rat receptors. These data highlight the importance of determining the pharmacological properties of behaviourally relevant compounds in diverse model species.
© 2020 British Society for Neuroendocrinology.

Entities:  

Keywords:  G protein-coupled receptor; GPCR; binding affinity; comparative; radioligand binding assay

Year:  2020        PMID: 32662552      PMCID: PMC7485222          DOI: 10.1111/jne.12882

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  32 in total

1.  Comparison of the distribution of oxytocin and vasopressin 1a receptors in rodents reveals conserved and derived patterns of nonapeptide evolution.

Authors:  Angela R Freeman; Elizabeth A Aulino; Heather K Caldwell; Alexander G Ophir
Journal:  J Neuroendocrinol       Date:  2020-02-11       Impact factor: 3.627

2.  Response of hamster circadian system to transitions between light and darkness.

Authors:  H E Albers
Journal:  Am J Physiol       Date:  1986-04

3.  Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamsters.

Authors:  C F Ferris; H E Albers; S M Wesolowski; B D Goldman; S E Luman
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

4.  Behavioral effects of vasopressin and oxytocin within the medial preoptic area of the golden hamster.

Authors:  H E Albers; C F Ferris
Journal:  Regul Pept       Date:  1985-11-07

5.  Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

Authors:  Maria A Thomas; Jacqueline F Spencer; Marie C La Regina; Debanjan Dhar; Ann E Tollefson; Karoly Toth; William S M Wold
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

6.  Neural distribution of nonapeptide binding sites in two species of songbird.

Authors:  Cary H Leung; Christopher T Goode; Larry J Young; Donna L Maney
Journal:  J Comp Neurol       Date:  2009-03-10       Impact factor: 3.215

Review 7.  Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.

Authors:  Zhimin Song; H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2017-10-18       Impact factor: 8.606

8.  Conditioned defeat in the Syrian golden hamster (Mesocricetus auratus).

Authors:  M Potegal; K Huhman; T Moore; J Meyerhoff
Journal:  Behav Neural Biol       Date:  1993-09

Review 9.  Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.

Authors:  M Manning; A Misicka; A Olma; K Bankowski; S Stoev; B Chini; T Durroux; B Mouillac; M Corbani; G Guillon
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

10.  Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.

Authors:  Marta Busnelli; Elisabetta Bulgheroni; Maurice Manning; Gunnar Kleinau; Bice Chini
Journal:  J Pharmacol Exp Ther       Date:  2013-05-30       Impact factor: 4.030

View more
  2 in total

1.  Distribution of vasopressin 1a and oxytocin receptor protein and mRNA in the basal forebrain and midbrain of the spiny mouse (Acomys cahirinus).

Authors:  Jeanne M Powell; Kiyoshi Inoue; Kelly J Wallace; Ashley W Seifert; Larry J Young; Aubrey M Kelly
Journal:  Brain Struct Funct       Date:  2022-10-21       Impact factor: 3.748

2.  Estrogen Withdrawal Increases Postpartum Anxiety via Oxytocin Plasticity in the Paraventricular Hypothalamus and Dorsal Raphe Nucleus.

Authors:  Valerie L Hedges; Elizabeth C Heaton; Claudia Amaral; Lauren E Benedetto; Clio L Bodie; Breanna I D'Antonio; Dayana R Davila Portillo; Rachel H Lee; M Taylor Levine; Emily C O'Sullivan; Natalie P Pisch; Shantal Taveras; Hannah R Wild; Zachary A Grieb; Amy P Ross; H Elliott Albers; Laura E Been
Journal:  Biol Psychiatry       Date:  2020-11-24       Impact factor: 13.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.